CD276 and lung carcinoma: The ability of cam1615B7H3 TriKE to improve NK cell activity against B7-H3-expressing lung cancer (Figure S1D) was tested on normal donor PBMCs incubated with A549 and NCI-H322, two non-small cell lung cancer adenocarcinoma lines (Figure 5A,B).